Editas Medicine, Inc. Soared

Wed, Feb 19, 2025 at 07:27 PM

Editas Medicine, Inc. (EDIT:NASDAQ) shot up at $3.2, representing a gain of 83.9%. On Wed, Feb 19, 2025, EDIT:NASDAQ touched a New 2-Week High of $3.2. From Wed, Feb 05, 2025, the stock recorded 55.56% Up Days and 60.00% Green Days

About Editas Medicine, Inc. (EDIT:NASDAQ)

Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.

Top 10 Gainers:

JetAI Inc Com (JTAI:NASDAQ), 150%
F45 Training Holdings Inc. (FXLV:NYSE), 92.08%
Editas Medicine, Inc. (EDIT:NASDAQ), 83.91%
OSR Holdings Inc. (OSRH:NASDAQ), 75.56%
Sintx Technologies, Inc. (SINT:NASDAQ), 70.92%
Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 61.73%
Aureus Greenway Holdings Inc. (AGH:NASDAQ), 42.44%
HUHUTECH International Group Inc. (HUHU:NASDAQ), 32%
MicroVision, Inc. (MVIS:NASDAQ), 31.58%
ProPhase Labs, Inc. (PRPH:NASDAQ), 29.84%